World Health Organization Classification and Diagnosis of Mastocytosis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
World Health Organization Classification and Diagnosis of Mastocytosis
Authors
Keywords
-
Journal
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
Volume 43, Issue 4, Pages 627-649
Publisher
Elsevier BV
Online
2023-07-18
DOI
10.1016/j.iac.2023.04.011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022
- (2022) Michel Arock et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Global Classification of Mast Cell Activation Disorders An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium
- (2022) Peter Valent et al. Journal of Allergy and Clinical Immunology-In Practice
- Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice
- (2022) Peter Valent et al. Journal of Allergy and Clinical Immunology-In Practice
- Efficacy and Safety of Avapritinib in Previously Treated Patients with Advanced Systemic Mastocytosis
- (2022) Andreas Reiter et al. Blood Advances
- Avapritinib for Advanced Systemic Mastocytosis
- (2022) Jason Gotlib et al. BLOOD
- International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data
- (2022) Daniel A. Arber et al. BLOOD
- Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis
- (2022) Andreas Reiter et al. LEUKEMIA
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
- (2022) Joseph D. Khoury et al. LEUKEMIA
- Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study
- (2021) Javier I Muñoz-González et al. Lancet Haematology
- Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis (ECNM)
- (2021) Elisabeth Aberer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis
- (2021) Roberta Zanotti et al. LEUKEMIA
- Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial
- (2021) Jason Gotlib et al. NATURE MEDICINE
- Clinical Features and Survival of Patients with Indolent Systemic Mastocytosis defined by the Updated WHO Classification
- (2020) Jakub Trizuljak et al. ALLERGY
- New Developments in Diagnosis, Prognostication, and Treatment of Advanced Systemic Mastocytosis
- (2020) Andreas Reiter et al. BLOOD
- Omalizumab in the treatment of adult patients with mastocytosis: a systematic review
- (2020) Fatma Jendoubi et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Mast Cells in Inflammation and Disease: Recent Progress and Ongoing Concerns
- (2020) Stephen J. Galli et al. Annual Review of Immunology
- Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
- (2020) Georg Greiner et al. BLOOD
- Heritable risk for severe anaphylaxis associated with increased α-tryptase-encoding germline copy number at TPSAB1
- (2020) Jonathan J. Lyons et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine
- (2020) Peter Valent et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis
- (2019) Mohamad Jawhar et al. LEUKEMIA
- Proposed Diagnostic Algorithm for Patients With Suspected Mast Cell Activation Syndrome
- (2019) Peter Valent et al. Journal of Allergy and Clinical Immunology-In Practice
- Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis
- (2019) Javier I. Muñoz-González et al. BLOOD
- MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis
- (2019) Mohamad Jawhar et al. JOURNAL OF CLINICAL ONCOLOGY
- International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study
- (2019) Wolfgang R Sperr et al. Lancet Haematology
- Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis
- (2018) Nicole Naumann et al. GENES CHROMOSOMES & CANCER
- Hereditary Alpha Tryptasemia
- (2018) Jonathan J. Lyons IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Next-generation sequencing in systemic mastocytosis: Derivation of a mutation-augmented clinical prognostic model for survival
- (2016) Animesh Pardanani et al. AMERICAN JOURNAL OF HEMATOLOGY
- Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
- (2016) Peter Valent et al. BLOOD
- Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology
- (2016) Karin Hartmann et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis
- (2016) Iván Álvarez-Twose et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia
- (2016) I Alvarez-Twose et al. LEUKEMIA
- Well-differentiated systemic mastocytosis showed excellent clinical response to imatinib in the absence of known molecular genetic abnormalities
- (2016) Lanshan Huang et al. MEDICINE
- Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number
- (2016) Jonathan J Lyons et al. NATURE GENETICS
- Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
- (2016) Jason Gotlib et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mast cell sarcoma: new cases and literature review
- (2016) Jilliana Monnier et al. Oncotarget
- Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature
- (2016) Iván Alvarez-Twose et al. Oncotarget
- Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis
- (2015) Katharina Blatt et al. BLOOD
- Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis
- (2015) Tim Wiechers et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels
- (2015) Roberta Zanotti et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis
- (2015) M Arock et al. LEUKEMIA
- Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosis
- (2015) M Jawhar et al. LEUKEMIA
- Mast Cells, Mastocytosis, and Related Disorders
- (2015) Theoharis C. Theoharides et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis
- (2014) P. Valent et al. ALLERGY
- Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal
- (2014) P. Valent et al. ANNALS OF ONCOLOGY
- Diagnostic Criteria and Classification of Mastocytosis in 2014
- (2014) Cem Akin et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis
- (2014) Celalettin Ustun et al. JOURNAL OF CLINICAL ONCOLOGY
- ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases
- (2014) Gandhi Damaj et al. PLoS One
- Mast cell activation syndromes: definition and classification
- (2013) P. Valent ALLERGY
- Comprehensive mutational profiling in advanced systemic mastocytosis
- (2013) J. Schwaab et al. BLOOD
- CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis
- (2013) José M Morgado et al. HISTOPATHOLOGY
- Venom Immunotherapy in Patients with Clonal Mast Cell Disorders: Efficacy, Safety, and Practical Considerations
- (2013) Patrizia Bonadonna et al. Journal of Allergy and Clinical Immunology-In Practice
- Mast cell leukemia
- (2012) S. Georgin-Lavialle et al. BLOOD
- Systemic mastocytosis as a risk factor for severe Hymenoptera sting–induced anaphylaxis
- (2012) Iván Alvarez-Twose et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mast Cell Sarcoma: A Rare and Aggressive Entity—Report of Two Cases and Review of the Literature
- (2012) Sophie Georgin-Lavialle et al. JOURNAL OF CLINICAL ONCOLOGY
- Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis
- (2012) Fabiola Traina et al. PLoS One
- Severe Life-Threatening or Disabling Anaphylaxis in Patients with Systemic Mastocytosis: A Single-Center Experience
- (2011) Friedrich Wimazal et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal
- (2011) Peter Valent et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms
- (2011) Peter Valent et al. LEUKEMIA & LYMPHOMA
- Mastocytosis and insect venom allergy
- (2010) Patrizia Bonadonna et al. Current Opinion in Allergy and Clinical Immunology
- Mast cells in allergy and infection: Versatile effector and regulatory cells in innate and adaptive immunity
- (2010) Stephen J. Galli et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis
- (2010) T. M. Wilson et al. HAEMATOLOGICA
- Mast cell activation syndrome: Proposed diagnostic criteria
- (2010) Cem Akin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis
- (2010) Karl Sotlar et al. MODERN PATHOLOGY
- Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives
- (2010) Michel Arock et al. Expert Review of Hematology
- Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels
- (2009) Patrizia Bonadonna et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations
- (2009) Christine Bodemer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Variable presence ofKITD816Vin clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD)
- (2009) Karl Sotlar et al. JOURNAL OF PATHOLOGY
- Mast cells and mastocytosis
- (2008) D. D. Metcalfe BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started